Dual Immunotherapy Shows Activity in Clear Cell Gynecologic Cancers

By News Health
8 hours Ago

(MedPage Today) — Nivolumab (Opdivo) plus ipilimumab (Yervoy) showed significant activity in patients with advanced gynecologic clear cell carcinomas, according to results from a phase II nonrandomized trial.
Among 26 evaluable patients with…

Source link : https://www.medpagetoday.com/hematologyoncology/ovariancancer/116371

Author :

Publish date : 2025-07-03 15:00:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

House Approves Trump's Sweeping Tax Bill

3D printing could enable a safer long-term therapy for type 1 diabetes

Quantum computers are surprisingly random – but that's a good thing

States Sue After Trump Admin Releases Private Medicaid Data to Deportation Officials

Supreme Court's Medina Ruling Is a Blow to Medicaid Patients

Pandemic Surge in IBS, Chronic Idiopathic Constipation